Multiple Sclerosis News Today14d
FDA approves prefilled syringe formulation of Ani’s Cortrophin Gel
The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients with relapses.
Center for Biosimilars14d
More Ustekinumab Biosimilars Join US Market Share Fight
Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 ...
Business Wire18d
The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
The initial container systems will include 0.5 mL, 1 mL long, and 1 mL short syringes, along with 2R vials, all in ready-to-fill formats. Container filling can be performed via peristaltic pump or ...
manilatimes24d
ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe
PRINCETON, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval of Purified ...
Managed Healthcare Executive24d
Fresenius Kabi Launches Otulfi, the 4th Biosimilar of Stelara to Become Available
The FDA had approved Otulfi in September 2024 to treat Crohn’s disease, ulcerative colitis, psoriasis and active psoriatic arthritis. Information on pricing is not yet available. Fresenius Kabi has ...
ophthalmologytimes24d
FDA approves Purified Cortrophin Gel Prefilled Syringe from ANI Pharmaceuticals
Cortrophin Gel is a prescription medicine that is injected subcutaneously or intramuscularly indicated for severe acute and chronic allergic and inflammatory conditions affecting the eye. ANI ...